Item 1.
Financial Statements
Condensed Balance Sheet as of September 30, 2021 (unaudited) 2
Condensed Statements of Operations for the Three Months Ended September 30, 2021 and for the Period from March 11, 2021 (Inception) Through September 30, 2021 (unaudited) 3
​ Condensed Statement of Changes in Shareholders’ Deficit for the Period from March 11, 2021 (Inception) Through September 30, 2021 (unaudited) 4
​ Condensed Statement of Cash Flows for the Period from March 11, 2021 (Inception) Through September 30, 2021 (unaudited) 5
Notes to Condensed Financial Statements (unaudited) 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 24
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Item 4. Controls and Procedures 28
PART II OTHER INFORMATION
Item 1. Legal Proceedings 30
Item 1A. Risk Factors 30
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30
Item 3. Defaults Upon Senior Securities 30
Item 4. Mine Safety Disclosures 30
Item 5. Other Information 30
Item 6. Exhibits 31
Signatures 32
​
​
​
​
​
1
| ​ | ​ | ​ | ​ |
| Assets | ​ |
| Current Assets | ​ |
| Cash | $ | 1,006,126 |
| Prepaid expenses | ​ | 414,250 |
| Total Current Assets | ​ | ​ | 1,420,376 |
| Cash and marketable securities held in trust account | ​ | ​ | 219,613,318 |
| Prepaid expenses | ​ | ​ | 333,542 |
| Total Noncurrent Assets | ​ | ​ | 219,946,860 |
| Total Assets | ​ | $ | 221,367,236 |
| ​ | ​ | ​ | ​ |
| Liabilities and Shareholders' Deficit | ​ |
| Current Liabilities | ​ |
| Accounts payable | ​ | $ | 162,605 |
| Accrued expenses | ​ | ​ | 302,560 |
| Accrued offering costs | ​ | 542,000 |
| Total Current Liabilities | ​ | 1,007,165 |
| Promissory note payable - related party | ​ | ​ | 84,412 |
| Deferred underwriter's commission fee | ​ | ​ | 7,686,396 |
| Warrant liability | ​ | 8,135,002 |
| Total Liabilities | ​ | $ | 16,912,975 |
| ​ | ​ | ​ | ​ |
| Commitments and Contingencies (Note 8) | ​ |
| Class A ordinary shares subject to possible redemption, 21,961,131 shares at redemption value | ​ | ​ | 219,613,318 |
| Shareholders' Deficit | ​ |
| Preference shares, $ 0.0001 par value, 1,000,000 shares authorized; none issued and outstanding | ​ | ​ | — |
| Class A ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; none issued and outstanding (excluding 21,961,131 shares of Class A ordinary shares subject to redemption) | ​ | ​ | — |
| Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 5,490,283 shares issued and outstanding | ​ | 549 |
| Additional paid-in capital | ​ | - |
| Accumulated deficit | ​ | ( 15,159,606 ) |
| Total Shareholders' Deficit | ​ | ​ | ( 15,159,057 ) |
| Total Liabilities and Shareholders' Deficit | ​ | $ | 221,367,236 |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | For the Period from |
| ​ | ​ | ​ | ​ | ​ | March 11, 2021 |
| ​ | ​ | For the Three Months | ​ | (Inception) Through |
| ​ | Ended September 30, 2021 | September 30, 2021 |
| ​ | ​ | (unaudited) | ​ | (unaudited) |
| Formation and operating costs | ​ | $ | ( 589,667 ) | $ | ( 600,920 ) |
| Loss from operations | ​ | ​ | ( 589,667 ) | ​ | ​ | ( 600,920 ) |
| Other Income | ​ | ​ | ​ | ​ | ​ | ​ |
| Offering expenses related to warrant issuance | ​ | ​ | ( 519,498 ) | ​ | ​ | ( 519,498 ) |
| Change in fair value of warrant liabilities | ​ | ​ | 5,553,385 | ​ | ​ | 5,553,385 |
| Unrealized gain on securities held in trust | ​ | ​ | 2,008 | ​ | ​ | 2,008 |
| Total Other Income | ​ | ​ | 5,035,895 | ​ | 5,035,895 |
| Net Income | ​ | $ | 4,446,228 | ​ | $ | 4,434,975 |
| Basic and diluted weighted average shares outstanding, Redeemable Class A ordinary shares | ​ | ​ | 13,594,936 | ​ | ​ | 6,197,691 |
| Basic and diluted net income per share, Redeemable Class A ordinary shares | ​ | $ | 0.23 | ​ | $ | 0.38 |
| Basic and diluted weighted average shares outstanding, Non- Redeemable Class B ordinary shares | ​ | ​ | 5,629,916 | ​ | ​ | 5,469,765 |
| Basic and diluted net income per share, Non- Redeemable Class B ordinary shares | ​ | $ | 0.23 | ​ | $ | 0.38 |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | Ordinary Shares | ​ | Additional | ​ | ​ | ​ | ​ | Total |
| ​ | ​ | Class A | ​ | Class B | ​ | Paid-in | ​ | Accumulated | ​ | Shareholders' |
| ​ | Shares | Amount | Shares | Amount | Capital | Deficit | Deficit |
| Balance - March 11, 2021 (inception) | — | ​ | — | ​ | — | ​ | — | ​ | — | ​ | — | ​ | — |
| Issuance of founder shares | — | ​ | ​ | — | ​ | 575,000 | ​ | $ | 575 | ​ | $ | 24,425 | ​ | $ | — | ​ | $ | 25,000 |
| Net loss | ​ | ​ | — | ​ | ​ | ​ | — | ​ | — | ​ | ​ | ( 11,069 ) | ​ | ( 11,069 ) |
| Balance-March 31, 2021 | — | ​ | ​ | — | ​ | 575,000 | ​ | ​ | 575 | ​ | ​ | 24,425 | ​ | ​ | ( 11,069 ) | ​ | ​ | 13,931 |
| Net loss | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | ( 183 ) | ​ | ​ | ( 183 ) |
| Balance-June 30, 2021 | ​ | — | ​ | ​ | — | ​ | 575,000 | ​ | ​ | 575 | ​ | ​ | 24,425 | ​ | ​ | ( 11,252 ) | ​ | ​ | 13,748 |
| Forfeiture of founder shares | ​ | — | ​ | ​ | — | ​ | ( 259,717 ) | ​ | ​ | ( 26 ) | ​ | ​ | 26 | ​ | ​ | — | ​ | ​ | — |
| Redeemable Share accretion | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | ( 24,451 ) | ​ | ​ | ( 19,594,582 ) | ​ | ​ | ( 19,619,033 ) |
| Net income | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 4,446,228 | ​ | ​ | 4,446,228 |
| Balance-September 30, 2021 | ​ | — | ​ | $ | — | ​ | 5,490,283 | ​ | $ | 549 | ​ | $ | — | ​ | $ | ( 15,159,606 ) | ​ | $ | ( 15,159,057 ) |

| ​ | ​ | ​ | ​ |
| Cash flows from operating activities: | ​ |
| Net income | ​ | ​ | 4,434,975 |
| Adjustments to reconcile cash used in operating activities: | ​ | ​ | ​ |
| Change in warrant liability | ​ | ​ | ( 5,553,385 ) |
| Offering costs allocated to warrants | ​ | ​ | 519,498 |
| Unrealized gain on securities held in trust | ​ | ​ | ( 2,008 ) |
| Changes in operating assets and liabilities: | ​ | ​ | ​ |
| Prepaid expenses | ​ | ​ | ( 747,792 ) |
| Accounts payable | ​ | ​ | 162,605 |
| Accrued expenses | ​ | ​ | 302,560 |
| Due to related party | ​ | ​ | 84,412 |
| Net cash used in operating activities | ​ | ​ | ( 799,135 ) |
| Cash Flows from Investing Activities: | ​ | ​ | ​ |
| Investments Held in Trust Account | ​ | ​ | ( 219,611,310 ) |
| Net cash used in investing activities | ​ | ​ | ( 219,611,310 ) |
| Cash Flows from Financing Activities: | ​ | ​ | ​ |
| Proceeds from sale of Class B ordinary shares to Sponsor | ​ | ​ | 25,000 |
| Proceeds from sale of Units, net of underwriting discount | ​ | ​ | 215,219,083 |
| Proceeds from sale of Private Placement Warrants | ​ | ​ | 6,392,228 |
| Payment of offering costs | ​ | ​ | ( 219,740 ) |
| Net cash provided by financing activities | ​ | ​ | 221,416,571 |
| ​ | ​ | ​ | ​ |
| Net change in cash | ​ | ​ | 1,006,126 |
| Cash at beginning of period | ​ | ​ | — |
| Cash at end of period | ​ | $ | 1,006,126 |
| ​ | ​ | ​ | ​ |
| Supplemental disclosure of cash flow information: | ​ | ​ | ​ |
| Record ordinary shares subject to redemption | ​ | $ | ( 219,613,318 ) |
| Deferred underwriting fee payable | ​ | $ | ( 7,686,396 ) |
| Deferred offering costs included in accrued offering costs | ​ | $ | 542,000 |
| Deferred offering costs included in due to related party | ​ | $ | 84,412 |

XPAC Acquisition CorporationNotes to Condensed Financial Statements(Unaudited) NOTE 1 — ORGANIZATION AND BUSINESS BACKGROUNDXPAC Acquisition Corp. (the “Company”) was incorporated in the Cayman Islands on March 11, 2021. The Company was formed for the purpose of entering into a merger, amalgamation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.As of September 30, 2021, the Company had not commenced any operations. All activity for the period from March 11, 2021 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.The registration statement for the Company’s Initial Public Offering was declared effective on July 29, 2021 (the “Effective Date”). On August 3, 2021, the Company consummated the IPO of 20,000,000 Units at $ 10.00 per Unit, generating gross proceeds of $ 200,000,000 , which is discussed in Note 3. Simultaneously with the closing of the IPO, the Company consummated the sale of 4,000,000 Private Placement Warrants (the “Private Warrants”) at a price of $ 1.50 per Private Warrant in a private placement to certain funds and accounts managed by XPAC Sponsor, LLC (the “Sponsor”) generating proceeds of $ 6,000,000 from the sale of the Private Placement Warrants, which is discussed in Note 4.The Company had granted the underwriters in the Initial Public Offering (the “Underwriters”) a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, if any. On August 16, 2021, the underwriter partially exercised the over-allotment option and on August 19, 2021, purchased an additional 1,961,131 Units from the Company (the “Over-Allotment Units”), generating gross proceeds of $ 19,611,310 . Simultaneously with the closing of the exercise of the over-allotment option, the Company consummated the sale of 261,485 additional Private Placement Warrants at a purchase price of $ 1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $ 392,228 .​ 6
NOTE 1 — ORGANIZATION AND BUSINESS BACKGROUND (Cont.)The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80 % of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the Company’s signing a definitive agreement in connection with its initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50 % or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Management agreed that an amount equal to at least $ 10.00 per Unit sold in the Initial Public Offering, including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (“Trust Account”), located in the United States and invested only in U.S. government treasury bills, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to the limitations described herein.The amount in the trust account is initially anticipated to be $ 10.00 per public share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriter. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of our initial business combination with respect to our warrants. Our initial shareholders, directors and officers have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with the completion of our initial business combination.The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $ 5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Association (the “Amended and Restated Certificate of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.​ 7
NOTE 1 — ORGANIZATION AND BUSINESS BACKGROUND (Cont.)Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15 % or more of the Public Shares, without the prior consent of the Company.The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100 % of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to shareholders rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.The Company will have until 24 months from the closing of the Initial Public Offering to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $ 100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive it right to its deferred underwriting commission (see Note 8) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($ 10.00 ).​ 8
NOTE 1 — ORGANIZATION AND BUSINESS BACKGROUND (Cont.)In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $ 10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay franchise and income taxes. This liability will not apply with respect to claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.Going Concern ConsiderationAt September 30, 2021, the Company had $ 1,006,126 in cash and working capital of $ 413,211 . The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plan to consummate a Business Combination will be successful or successful within the Combination Window. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.Risks and UncertaintiesManagement is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Initial Public Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. ​​9
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of PresentationThe accompanying audited financial statements are presented in in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying audited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented. The results for the period for the period ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth CompanyThe Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of EstimatesThe preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.​ 10
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)Use of Estimates (Cont.)Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Income taxesThe Company accounts for income taxes in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under the asset and liability method, as required by this accounting standard, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities in the financial statements and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to the period when assets are realized or liabilities are settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in the operation of statement in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Offering costsThe Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—”Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged to stockholders’ equity or the statement of operations based on the relative value of the Public Warrants and the Private Placement Warrants to the proceeds received from the Units sold upon the completion of the IPO and any over-allotment exercised. Accordingly, on August 3, 2021, offering costs totaling $ 11,761,739 (consisting of $ 4,000,000 of underwriting fee, $ 7,000,000 of deferred underwriting fee and $ 761,739 of other offering costs) were recognized with $ 477,711 included in accumulated deficit as an allocation for the Public Warrants and the Private Placement Warrants, and $ 11,284,028 included in additional paid-in capital.​ 11
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | For the Period from March 11, |
| ​ | ​ | For the three months ended | ​ | 2021 (Inception) Through |
| ​ | ​ | September 30, 2021 | ​ | September 30, 2021 |
| ​ | ​ | Redeemable | Non-Redeemable | Redeemable | Non-Redeemable |
| ​ | ​ | Class A | ​ | Class B ordinary | ​ | Class A ordinary | ​ | Class B ordinary |
| ​ | ordinary shares | shares | shares | shares |
| Basic and diluted net income (loss) per share | ​ | ​ | ​ | ​ |
| Numerator: | ​ | ​ | ​ | ​ |
| Allocation of net income | ​ | $ | 3,144,169 | ​ | $ | 1,302,059 | ​ | $ | 2,355,835 | ​ | $ | 2,079,140 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Denominator: | ​ | ​ | ​ | ​ |
| Weighted-average shares outstanding | ​ | 13,594,936 | ​ | 5,629,916 | ​ | 6,197,691 | ​ | 5,469,765 |
| Basic and diluted net income (loss) per share | ​ | $ | 0.23 | ​ | $ | 0.23 | ​ | $ | 0.38 | ​ | $ | 0.38 |

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.) Fair Value of Financial InstrumentsThe fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Warrant LiabilityThe Company accounts for warrants for the Company’s ordinary shares that are not indexed to its own shares as liabilities at fair value on the balance sheet. The warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the statement of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the ordinary share warrants. At that time, the portion of the warrant liability related to the ordinary share warrants will be reclassified to additional paid-in capital. Related PartiesParties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence. Cash and Cash EquivalentsThe Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had cash of $ 1,006,126 as of September 30, 2021. 13
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.) Investments Held in Trust AccountAt September 30, 2021, the $ 219,613,318 held in the Trust Account was held in money market funds, which are invested in U.S. Treasury securities. The investments held in the Trust Account are presented at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in unrealized gains on investments held in trust account on the accompanying condensed statements of operations. The estimated fair value of investments held in the Trust Account are determined using available market information. Class A Ordinary Shares Subject to Possible RedemptionThe Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity." Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholder’s equity. The Company's ordinary shares feature certain redemption rights that is considered to be outside of the Company's control and subject to the occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholder’s equity section of the Company's balance sheet. Recent Accounting PronouncementsIn August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity's Own Equity (Subtopic 815-40). The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity's own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. This guidance is effective as of January 1, 2022 (Early adoption is permitted effective January 1, 2021). The Company is currently evaluating the effect the updated standard will have on its financial position, results of operations or financial statement disclosure.The Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on the results of operations, financial condition, or cash flows, based on the current information. ​​14
NOTE 3 — INITIAL PUBLIC OFFERINGPursuant to the Initial Public Offering on August 3, 2021, the Company sold 20,000,000 Units at a price of $ 10.00 per Unit. Each Unit consisted of one share of Class A ordinary shares and one-third of one warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $ 11.50 per share, subject to adjustment (see Note 6).On August 16, 2021, the underwriter partially exercised the over-allotment option and on August 19, 2021, purchased an additional 1,961,131 Units from the Company (the “Over-Allotment Units”), generating gross proceeds of $ 19,611,310 . In connection with the Underwriter’s partial exercise of their over-allotment option, the Sponsor purchased an additional 261,485 Private Placement Warrants (the “Additional Private Placement Warrants”), generating gross proceeds to the Company of approximately $ 392,228 .An aggregate of $ 10.00 per Unit sold in the Initial Public Offering was held in the Trust Account and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. ​ NOTE 4 — PRIVATE PLACEMENTSimultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 4,000,000 Private Placement Warrants, at a price of $ 1.50 per Private Placement Warrant, for an aggregate of $ 6,000,000 , in a private placement. Simultaneously, with the closing of the exercise of the over-allotment option, the Company completed the sale of an additional 261,485 Private Placement Warrants to the Sponsor, at a purchase price of $ 1.50 per Private Warrant, generating gross proceeds of $ 392,228 . A portion of the proceeds from the sale of Private Placement Warrants were added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless ​15
NOTE 5 — RELATED PARTY TRANSACTIONSFounder SharesIn March 2021, the Sponsor purchased 5,750,000 shares of the Company’s Class B ordinary shares (the “Founder Shares”) for an aggregate purchase price of $ 25,000 . This amount was paid on behalf of the Company to cover certain expenses. The Founder Shares include an aggregate of up to 750,000 shares subject to forfeiture by the Sponsor to the extent that the underwriter’s overallotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent approximately 20 % of the Company’s issued and outstanding shares after the Initial Public Offering. Since the underwriter did not exercise the over-allotment option in full, the Sponsor forfeited 259,717 Class B ordinary shares, which were forfeited by the Company. As a result of such forfeiture, there are currently 5,490,283 Class B ordinary shares issued and outstanding.The Sponsor and the Company’s directors and executive officers have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $ 12.00 per share (as adjusted for stock splits, stock reorganizations, recapitalizations and the like) for any 20 trading days within any 30 -trading day period commencing at least 120 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, stock exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their shares of Class A ordinary shares for cash, securities or other property.Promissory Note — Related PartyIn March 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $ 300,000 . As of September 30, 2021, the Company had drawn down $ 84,412 under the promissory note to pay for offering expenses. The Promissory Note was non-interest bearing and the amount of $ 84,412 is still owed as of September 30, 2021.Related Party LoansIn order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor may, but is not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. At the lender’s discretion, up to $ 1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $ 1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021, the Company had no outstanding borrowings under the Working Capital Loans.Administrative Support AgreementThe Company has agreed, commencing on the date that the Company’s securities are first listed on a U.S. national securities exchange through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $ 10,000 per month for office space, secretarial, and administrative support, when needed. As of September 30, 2021, the Company had not utilized the office space, secretarial, or administrative support and as result has not incurred or accrued for any expense related to this agreement. 16
NOTE 5 — RELATED PARTY TRANSACTIONS (Cont.)Advisory Services AgreementThe Company engaged XP Investimentos Corretora de Câmbio, Títulos e Valores Mobiliários S.A., an indirect, wholly-owned subsidiary of XP, Inc. and an affiliate of the Sponsor, to provide financial consulting services, consisting of a review of deal structure and terms and related advice in connection with this offering, for which it received a fee of $ 1,725,443.24 of the cash underwriting paid to the Underwriter. See Note 8 below for further discussion of the Underwriter Agreement. ​ NOTE 6 — SHAREHOLDER’S EQUITYPreference shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $ 0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2021, there were no preference shares issued or outstanding.Class A ordinary shares — The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $ 0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At September 30, 2021, there were 21,961,131 Class A ordinary shares issued and no shares outstanding, excluding 21,961,131 shares subject to possible redemption.Class B ordinary shares — The Company is authorized to issue 20,000,000 shares of Class B ordinary shares with a par value of $ 0.0001 per share. At September 30, 2021, there were 5,490,283 shares of Class B ordinary shares issued and outstanding. The shares collectively represent 20 % of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters submitted to a vote of shareholders except as required by law.The shares of Class B ordinary shares (founder shares) will automatically convert into shares of Class A ordinary shares at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20 % of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the Initial Public Offering plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination).Refer to Note 3 and Note 9 for discussion of the initial public offering that occurred on August 3, 2021. ​ NOTE 7 — WARRANT LIABILITIESPublic Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 12 months from the closing of the Initial Public Offering and (b) 30 days after the completion of a Business Combination. 17
| ● | in whole and not in part; |
| ● | at a price of $ 0.01 per warrant; |
| ● | upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and |
| ● | if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company will send the notice of redemption to the warrant holders (referred to as the “Reference Value”) equals or exceeds $ 18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Redeemable Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”). |

| ● | in whole and not in part; |
| ● | at $ 0.10 per warrant; |
| ● | upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares; |
| ● | if, and only if, the Reference Value (as defined above under “— Redemption of warrants when the price per share of our Class A ordinary shares equals or exceeds $ 18.00 ”) equals or exceeds $ 10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Anti-dilution Adjustments”); and |
| ● | if the Reference Value is less than $ 18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |

NOTE 7 — WARRANTS (Cont.)As of September 30, 2021, there were 7,320,377 Public Warrants and 4,261,485 Private Placement Warrants outstanding. The Company accounts for the Public Warrants and Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because an event that is not within the entity's control could require net cash settlement the warrants do not meet the criteria for equity classification and as a result each warrant must be recorded as a derivative liability.The accounting treatment of derivative financial instruments required that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification. ​ NOTE 8 — COMMITMENTS AND CONTINGENCIESRegistration and Shareholder RightsThe holders of the Founder Shares and Private Placement Warrants (and any shares of Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights and shareholder agreement to be signed prior to or on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.Underwriter AgreementIn connection with the Initial Public Offering, the underwriters were granted a 45-day option from the date of the prospectus to purchase up to 3,000,000 additional Units to cover over-allotments. On August 16, 2021, the underwriter partially exercised the over-allotment option and on August 19, 2021, purchased an additional 1,961,131 Units at an offering price of $ 10.00 per Unit, generating gross proceeds of $ 19,611,310 to the Company.The underwriters were paid a cash underwriting discount of $ 0.20 per Unit, or $ 4,392,226 in the aggregate upon the closing of the Initial Public Offering and the partial exercise of the over-allotment option. In addition, the underwriters will be entitled to a deferred fee of $ 0.35 per Unit, or $ 7,686,396 in the aggregate. Subject to the terms of the underwriting agreement, (i) the deferred fee will be placed in the Trust Account and released to the underwriters only upon the completion of a Business Combination and (ii) the deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination. ​20
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | (Level 1) | (Level 2) | (Level 3) |
| Assets | ​ | ​ | ​ |
| Cash and marketable securities held in trust account | ​ | $ | 219,613,318 | ​ | $ | — | ​ | $ | — |
| Liabilities | ​ | ​ | ​ |
| Public Warrants | ​ | $ | 5,124,264 | ​ | $ | — | ​ | $ | — |
| Private Placement Warrants | ​ | $ | — | ​ | $ | — | ​ | $ | 3,010,738 |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | Private | Public |
| ​ | ​ | Warrant | ​ | Warrant |
| Fair Value as of August 3, 2021 (IPO date) | ​ | $ | 4,770,000 | ​ | $ | 7,838,000 |
| Change in fair value of warrant liabilities | ​ | 311,820 | ​ | 768,567 |
| Fair Value as of August 19, 2021 (over-allotment date) | ​ | $ | 5,081,820 | ​ | $ | 8,606,567 |
| Transfer out of Level 3 | ​ | — | ​ | ( 8,606,567 ) |
| Change in fair value of warrant liabilities | ​ | ( 2,071,081 ) | ​ | — |
| Fair Value as of September 30, 2021 | ​ | $ | 3,010,738 | ​ | $ | — |
| ​ | ​ | ​ | ​ | ​ |
| ​ | Private Warrant |
| Stock price | ​ | $ | 9.70 | ​ |
| Exercise price | ​ | $ | 11.50 | ​ |
| Risk-free rate | ​ | 1.12 | % |
| Expected term to merger | ​ | 0.83 yrs. | ​ |
| Expected term of warrants | ​ | 5.83 yrs. | ​ |
| Estimated probability of a successful merger | ​ | 90 | % |
| Callable | ​ | No | ​ |
| Volatility | ​ | 12.72 | % |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | As Previously | ​ | ​ | ​ | ​ |
| Balance Sheet as of August 3, 2021 (audited) | ​ | Reported | ​ | Adjustment | ​ | As Restated |
| Class A ordinary shares subject to possible redemption | ​ | $ | 176,643,160 | ​ | $ | 23,356,840 | ​ | $ | 200,000,000 |
| Class A ordinary shares | ​ | $ | 237 | ​ | $ | ( 237 ) | ​ | $ | — |
| Class B ordinary shares | ​ | $ | 575 | ​ | $ | — | ​ | $ | 575 |
| Additional paid-in capital | ​ | $ | 5,489,003 | ​ | $ | ( 5,489,003 ) | ​ | $ | — |
| Accumulated deficit | ​ | $ | ( 489,807 ) | ​ | $ | ( 17,867,600 ) | ​ | $ | ( 18,357,407 ) |
| Total Shareholders’ Equity (Deficit) | ​ | $ | 5,000,005 | ​ | $ | ( 23,356,840 ) | ​ | $ | ( 18,356,835 ) |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Pro Forma Balance Sheet as of August 3, 2021 (audited) | ​ | ​ | ​ |
| Class A ordinary shares subject to possible redemption | ​ | $ | 194,487,690 | ​ | $ | 25,123,620 | ​ | $ | 219,611,310 |
| Class A ordinary shares | ​ | $ | 251 | ​ | $ | ( 251 ) | ​ | $ | — |
| Class B ordinary shares | ​ | $ | 549 | ​ | $ | — | ​ | $ | 549 |
| Additional paid-in capital | ​ | $ | 5,530,795 | ​ | $ | ( 5,530,795 ) | ​ | $ | — |
| Accumulated deficit | ​ | $ | ( 531,593 ) | ​ | $ | ( 19,592,574 ) | ​ | $ | ( 20,124,167 ) |
| Total Shareholders’ Equity (Deficit) | ​ | $ | 5,000,002 | ​ | $ | ( 25,123,620 ) | ​ | $ | ( 20,123,618 ) |

ITEM 2.
This Quarterly Report on Form 10-Q includes forward-looking statements. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Factors that might cause or contribute to such forward-looking statements include, but are not limited to, those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The following discussion should be read in conjunction with our financial statements and related notes thereto included elsewhere in this report.
Overview
We are a blank check company incorporated on March 11, 2021 as a Cayman Islands corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions directly or indirectly, with any business combination target with respect to an initial business combination with us. In addition, we have not contacted any of the prospective target businesses that XPAC had considered and rejected while such entity was a blank check company searching for target businesses to acquire. While our efforts in identifying a prospective target business for our initial business combination will not be limited to a particular industry or geographic region, we intend to initially focus our search on identifying a prospective target business experiencing very high-growth. We intend to effectuate our initial business combination using cash from the proceeds of this offering, shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, additional equity raised through a public or private offering, or a combination of the foregoing.
We expect to incur significant costs in the pursuit of our initial Business Combination. We cannot assure you that our plans to raise capital or to complete our initial Business Combination will be successful.
Results of Operations and Known Trends or Future Events
The Company has neither engaged in any significant business operations nor generated any revenues to date. All activities to date relate to the Company’s formation and initial public offering (“Initial Public Offering”). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and will recognize other income and expense related to the change in fair value of warrant liabilities. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. The Company has selected December 31 as its fiscal year end.
For the period from March 11, 2021 (inception) through September 30, 2021 and the three months ended September 30, 2021, we had a net income of $4,434,975 and $4,446,228, respectively, which consisted of expenses incurred, a gain on the fair value of warrant liabilities and a gain on securities held in trust.
24
Liquidity and Capital ResourcesFor the period from March 11, 2021 (inception) through September 30, 2021, net cash used in operating activities was $799,135 which was due to our net income of $4,434,975, expensed offering costs of $519,498, partially offset by the changes in working capital accounts of $198,215 and the change in fair value of warrant liability of $5,553,385, and unrealized gain on investments held in Trust Account of $2,008. For the period from March 11, 2021 (inception) through September 30, 2021, net cash used in investing activities of $219,611,310 was the result of the amount of net proceeds from the Initial Public Offering and the private placement sale of warrants being deposited to the Trust Account.Net cash provided by financing activities for the for the period from March 11, 2021 (inception) through September 30, 2021 of $221,416,571 was comprised of $25,000 in proceeds from issuance of Class B ordinary shares to Sponsor, $215,219,083 in proceeds from the issuance of Units in the Initial Public Offering net of underwriter's discount paid and $6,392,228 in proceeds from the issuance of warrants in a private placement to our Sponsor, partially offset by payment of $219,740 for offering costs associated with the Initial Public Offering.On August 3, 2021, we consummated our initial public offering of 20,000,000 units. Each Unit consisted of one share of Class A ordinary shares of the Company, par value $0.0001 per share (the “Public Shares”) and one-third of one redeemable warrant of the Company, with each whole warrant entitling the holder thereof to purchase one share of Class A ordinary shares for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $200,000,000. The Company granted the underwriters a 45-day option to purchase up to 3,000,000 additional Units solely to cover over-allotments.Simultaneously with the consummation of the Initial Public Offering, we completed the private sale of 4,000,000 warrants to XPAC Sponsor, LLC, our Sponsor, at a purchase price of $1.50 per warrant (the “Private Placement Warrants”), generating gross proceeds of $6,000,000. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the initial public offering held in a trust account (the “Trust Account”). If we do not complete our initial business combination within 24 months from the closing of the initial public offering, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.On August 16, 2021, the underwriter partially exercised the over-allotment option and on August 19, 2021, purchased an additional 1,961,131 Units from the Company (the “Over-Allotment Units”) at $10.00 per Unit, generating additional gross proceeds of $19,611,310 to the Company. In addition, the Company issued 261,485 Private Placement Warrants to the Sponsor. The underwriters have the right to exercise the remaining portion of the over-allotment option during the aforementioned 45-day period.We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less taxes payable and deferred underwriting commissions), to complete our initial business combination. We may withdraw interest income (if any) to pay income taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the trust account. We expect the interest income earned on the amount in the trust account (if any) will be sufficient to pay our income taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our directors and officers may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust 25
account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the private placement warrants issued to our sponsor. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a “no-shop” provision (a provision designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would be used as a down payment or to fund a “no-shop” provision would be determined based on the terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target businesses. We do not believe we will need to raise additional funds following this offering in order to meet the expenditures required for operating our business. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination.As indicated in the accompanying financial statements, at September 30, 2021 we had $1,006,126 cash and working capital of $413,211. Further, we expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.Off-Balance Sheet ArrangementsWe did not have any off-balance sheet arrangement as of September 30, 2021.Contractual ObligationsAs of September 30, 2021, we did not have any long-term debt, capital or operating lease obligations.We entered into an administrative services agreement pursuant to which we will pay an affiliate of one of our directors for office space and secretarial and administrative services provided to members of our management team, in an amount not to exceed $10,000 per month.Critical Accounting PoliciesManagement’s discussion and analysis of our results of operations and liquidity and capital resources are based on our unaudited financial information. We describe our significant accounting policies in Note 2 – Summary of Significant Accounting Policies, of the Notes to Financial Statements included in this report. Our unaudited financial statements have been prepared in accordance with U.S. GAAP. Certain of our accounting policies require that management apply significant judgments in defining the appropriate assumptions integral to financial estimates. On an ongoing basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. Judgments are based on historical experience, terms of existing contracts, industry trends and information available from outside sources, as appropriate. However, by their 26
nature, judgments are subject to an inherent degree of uncertainty, and, therefore, actual results could differ from our estimates.Recent Accounting StandardsIn August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity's Own Equity (Subtopic 815-40). The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity's own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. This guidance is effective as of January 1, 2022 (Early adoption is permitted effective January 1, 2021). The Company is currently evaluating the effect the updated standard will have on its financial position, results of operations or financial statement disclosure.The Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on the results of operations, financial condition, or cash flows, based on the current information.JOBS ActThe JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an independent registered public accounting firm’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the independent registered public accounting firm’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of this offering or until we are no longer an “emerging growth company,” whichever is earlier.​
Item 3. Quantitative and Qualitative Disclosures About Market Risk
The net proceeds of this offering and the sale of the private placement units held in the trust account will be invested in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
​
27
Item 4. Controls and Procedures
We are not currently required to maintain an effective system of internal controls as defined by Section 404 of the Sarbanes-Oxley Act. We will be required to comply with the internal control requirements of the Sarbanes- Oxley Act for the fiscal year ending December 31, 2022. Only in the event that we are deemed to be a large accelerated filer or an accelerated filer and no longer an emerging growth company would we be required to comply with the independent registered public accounting firm attestation requirement. Further, for as long as we remain an emerging growth company as defined in the JOBS Act, we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirement.
Prior to the closing of this offering, we have not completed an assessment, nor has our independent registered public accounting firm tested our systems, of internal controls. We expect to assess the internal controls of our target business or businesses prior to the completion of our initial business combination and, if necessary, to implement and test additional controls as we may determine are necessary in order to state that we maintain an effective system of internal controls. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy of internal controls. Many small and mid-sized target businesses we may consider for our initial business combination may have internal controls that need improvement in areas such as:
| ● | staffing for financial, accounting and external reporting areas, including segregation of duties; |

| ● | reconciliation of accounts; |

| ● | proper recording of expenses and liabilities in the period to which they relate; |

| ● | evidence of internal review and approval of accounting transactions; |

| ● | documentation of processes, assumptions and conclusions underlying significant estimates; and documentation of accounting policies and procedures. |

Because it will take time, management involvement and perhaps outside resources to determine what internal control improvements are necessary for us to meet regulatory requirements and market expectations for our operation of a target business, we may incur significant expenses in meeting our public reporting responsibilities, particularly in the areas of designing, enhancing, or remediating internal and disclosure controls. Doing so effectively may also take longer than we expect, thus increasing our exposure to financial fraud or erroneous financing reporting.
Once our management’s report on internal controls is complete, we will retain our independent registered public accounting firm to audit and render an opinion on such report when required by Section 404 of the Sarbanes-Oxley Act. The independent registered public accounting firm may identify additional issues concerning a target business’s internal controls while performing their audit of internal control over financial reporting.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, solely due to the material weakness described below, our disclosure controls and procedures were not effective as of September 30, 2021.
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal
28
executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.Changes in Internal Control over Financial ReportingThere was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2021 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, except as described below.Our internal control over financial reporting did not result in the proper classification of the Class A redeemable ordinary shares within our previously issued August 3, 2021 Balance Sheet and the August 3, 2021 Pro Forma Balance Sheet. In those balance sheets the Company determined that the Class A ordinary shares subject to possible redemption to be equal to the redemption value of the Public Shares, while also taking into consideration that the redemption cannot result in net tangible assets being less than $5,000,001. After discussion and evaluation, including with our independent auditors, we have concluded that while provisions in the Company’s charter may result in the Company being unable to redeem all of the Redeemable Shares in certain situations, the Redeemable Shares still contain redemption provisions which are outside of the Company’s control and therefore should be classified outside of permanent equity. Therefore, management concluded that the redemption value should include all Public Shares subject to possible redemption, resulting in the Class A ordinary shares subject to possible redemption being equal to the full redemption value of the Public Shares.To respond to this material weakness, we have devoted, and plan to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance our system of evaluating and implementing the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.​29
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
None.
​
Item 1A. Risk Factors
Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our S-1 filed with the SEC on May 13, 2021. As of the date of this report, there have been no material changes to the risk factors disclosed in our final prospectus filed with the SEC.
​
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
In March 2021, our sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of us in exchange for the issuance of 5,750,000 Class B ordinary shares, par value $0.0001 per share, for an aggregate purchase price of $25,000, or approximately $0.004 per share. In May 2021, our sponsor transferred 30,000 founder shares to each of Ana Cabral-Gardner, Denis Barros Pedreira and Camilo de Oliveira Tedde, our independent directors. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the issued and outstanding ordinary shares upon completion of this offering. Such securities were issued in connection with our incorporation pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D.
No underwriting discounts or commissions were paid with respect to such sales.
​
Item 3. Defaults Upon Senior Securities
None.
​
Item 4. Mine Safety Disclosures
Not applicable.
​
Item 5. Other Information
None.
​
​
30
Item 6. Exhibits
INDEX TO EXHIBITS
​
| ExhibitNumber | Description |
| ​ | ​ | ​ |
| 31.1* | ​ | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934. |
| 31.2* | ​ | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934. |
| 32.1*(1) | ​ | Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2*(1) | ​ | Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant t o Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.INS* | ​ | XBRL Instance Document |
| 101.SCH* | ​ | XBRL Taxonomy Extension Schema Document |
| 101.CAL* | ​ | SXRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF* | ​ | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | ​ | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE* | ​ | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | ​ | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

*Filed herewith.
**Management contract or compensatory plan, contract or arrangement.
​
| (1) | The certifications on Exhibit 32 hereto are deemed not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act. |

​
​
31
| SIGNATURE | TITLE | DATE |
| /s/ Chu Chiu Kong | Chief Executive Officer | November 12, 2021 |
| Chu Chiu Kong | (principal executive officer) |
| /s/ Fabio Kann | Chief Financial Officer | November 12, 2021 |
| Fabio Kann | (principal financial and accounting officer) |


Question: What is the company's financial leverage ratio expressed as a multiple for the period ended on September 30, 2021?

Solution:
def solution():
    #Define variables name and value
    total_assets = 221367236  
    total_shareholders_equity = -15159057  
    #Do math calculation to get the answer
    leverage_ratio = total_assets / total_shareholders_equity
    answer = leverage_ratio
    return answer


Answer: -14.602968773057585